Advances and applications of biosensors in pulmonary hypertension
Zhi Liu,
No information about this author
Zhenghai Bai,
No information about this author
Xiang Chen
No information about this author
et al.
Respiratory Research,
Journal Year:
2025,
Volume and Issue:
26(1)
Published: April 15, 2025
Pulmonary
hypertension
(PH)
is
a
serious
disease
characterized
by
elevated
pulmonary
artery
pressure,
with
its
prevalence
and
incidence
continuously
increasing,
posing
threat
to
the
lives
of
many
patients
worldwide.
Due
complex
etiology
PH
lack
specificity
in
clinical
manifestations,
there
currently
effective
specific
methods
for
early
diagnosis
practice.
Biosensors
hold
significant
promise
detection,
therapeutic
monitoring,
prognostic
evaluation,
personalized
treatment
PH,
owing
their
rapid,
sensitive,
highly
selective
characteristics.
The
rapid
development
various
types
biosensors,
such
as
electrochemical
optical
microfluidic
wireless
combined
use
nanomaterials,
makes
accurate
detection
PH-related
biomarkers
possible.
Despite
broad
application
prospects
biosensors
field
challenges
remain
terms
sensitivity,
selectivity,
stability,
regulation.
This
article
reviews
main
pathophysiological
mechanisms
commonly
used
principles
summarizes
progress
research
well
current
challenges,
order
promote
further
in-depth
biosensor
technology,
thereby
improving
effects
PH.
Clinical
trial
number:
Not
applicable.
Language: Английский
Facilities in Molecular Biomarkers in Cardiology
Biomolecules,
Journal Year:
2024,
Volume and Issue:
14(8), P. 1025 - 1025
Published: Aug. 17, 2024
This
Special
Issue
of
Language: Английский
Identification of metabolic biomarkers in idiopathic pulmonary arterial hypertension using targeted metabolomics and bioinformatics analysis
Chuang Yang,
No information about this author
Yihang Liu,
No information about this author
Haikuo Zheng
No information about this author
et al.
Scientific Reports,
Journal Year:
2024,
Volume and Issue:
14(1)
Published: Oct. 25, 2024
Pulmonary
arterial
hypertension
(PAH)
is
a
life-threatening
disease
with
poor
prognosis,
and
metabolic
abnormalities
play
critical
role
in
its
development.
This
study
used
metabolomics,
machine
learning
algorithms
bioinformatics
to
screen
for
potential
biomarkers
associated
the
diagnosis
of
PAH.
In
this
study,
plasma
samples
were
collected
from
17
patients
diagnosed
idiopathic
pulmonary
(IPAH)
20
healthy
controls.
Plasma
metabolomic
profiling
was
performed
by
high-performance
liquid
chromatography-mass
spectrometry.
Gene
profiles
PAH
obtained
GEO
database.
Key
differentially
expressed
metabolites
(DEMs)
metabolism-related
genes
subsequently
identified
using
algorithms.
Twenty
differential
IPAH
(VIP
score
>
1
p
<
0
0.05),
enrichment
analysis
revealed
arginine
biosynthesis
pathway
as
most
altered
pathway.
Using
models,
including
least
absolute
shrinkage
selection
operator
(LASSO),
random
forest
(RF)
support
vector
(SVM),
we
extracted
key
that
correlated
clinical
phenotypes.
Our
results
suggested
five
metabolites,
kynurenine,
homoserine,
tryptophan,
AMP,
spermine,
are
IPAH.
Bioinformatics
also
3
genes,
MAPK6,
SLC7A11
CDC42BPA,
strongly
hypertension,
demonstrating
strong
predictive
power
relevance.
findings
some
metabolism
PH,
provided
crucial
information
about
complex
reprogramming
signals
may
lead
identification
useful
Language: Английский
Pulmonary hypertension post-liver transplant: A case report
World Journal of Gastrointestinal Surgery,
Journal Year:
2024,
Volume and Issue:
16(12), P. 3875 - 3880
Published: Nov. 27, 2024
BACKGROUND
Liver
transplantation
(LTx)
is
vital
in
patients
with
end-stage
liver
disease,
metabolic
dysfunction-associated
steatotic
disease
being
the
most
common
indication.
Primary
sclerosing
cholangitis
(PSC)
an
important
Portopulmonary
hypertension,
associated
portal
poses
a
significant
perioperative
risk,
making
pretransplant
screening
essential.
CASE
SUMMARY
We
report
case
of
41-year-old
woman
PSC
who
developed
severe
pulmonary
hypertension
years
after
successful
LTx.
She
presented
worsening
dyspnea
on
exertion
and
presyncope.
Diagnostic
evaluation
confirmed
precapillary
without
evidence
recurrent
hypertension.
Initial
management
Sildenafil
Macitentan
led
to
improvement
her
symptoms,
exercise
capacity,
biomarkers.
This
highlights
rare
development
de
novo
transplant
recipient
possibly
linked
autoimmune
processes
or
primary
itself.
The
patient’s
positive
response
combination
therapy
underscores
importance
prompt
diagnosis
aggressive
management.
CONCLUSION
In
conclusion,
arterial
post-LTx
but
serious
complication
poor
prognosis,
necessitating
further
research
better
understand
its
mechanisms
develop
effective
strategies
for
prevention
treatment.
Language: Английский